{"title":"疑似青光眼：谁是谁？","authors":"Mauricio Pérez González, Marcelo Vega Codd, Matías Perez Miranda, Gabriel Espinoza Torres","doi":"10.15406/aovs.2024.14.00453","DOIUrl":null,"url":null,"abstract":"Glaucoma is the second cause of blindness worldwide, being the first cause of irreversible blindness. It is estimated that in 2040 there will be around 111.8 million patients with glaucoma, reaching a 3.5% prevalence in patients between 40 and 80 years old; This situation can be preventable if we can identify early the cases at risk of developing the disease, who correspond to the suspected diagnosis of glaucoma.","PeriodicalId":287670,"journal":{"name":"Advances in Ophthalmology & Visual System","volume":"11 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Suspected glaucoma: who is who?\",\"authors\":\"Mauricio Pérez González, Marcelo Vega Codd, Matías Perez Miranda, Gabriel Espinoza Torres\",\"doi\":\"10.15406/aovs.2024.14.00453\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Glaucoma is the second cause of blindness worldwide, being the first cause of irreversible blindness. It is estimated that in 2040 there will be around 111.8 million patients with glaucoma, reaching a 3.5% prevalence in patients between 40 and 80 years old; This situation can be preventable if we can identify early the cases at risk of developing the disease, who correspond to the suspected diagnosis of glaucoma.\",\"PeriodicalId\":287670,\"journal\":{\"name\":\"Advances in Ophthalmology & Visual System\",\"volume\":\"11 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Ophthalmology & Visual System\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/aovs.2024.14.00453\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Ophthalmology & Visual System","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/aovs.2024.14.00453","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Glaucoma is the second cause of blindness worldwide, being the first cause of irreversible blindness. It is estimated that in 2040 there will be around 111.8 million patients with glaucoma, reaching a 3.5% prevalence in patients between 40 and 80 years old; This situation can be preventable if we can identify early the cases at risk of developing the disease, who correspond to the suspected diagnosis of glaucoma.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
